SEDIA BIOSCIENCES CORPORATION

Website: Company Website

Address: 9590 Sw Gemini Dr Ste 120, Beaverton, Oregon, 97008-7166

Phone: 503-459-4159 x300

Fax: 503-459-4168

Contact Person: RONALD MINK

Legal Structure: Corporation

Year Established: 2009

Business Type: Manufacturing (50 %), Research and Development (50 %)

Sales/Service Area: Aruba; Algeria; Albania; Argentina; Australia; Austria; Bahrain; Barbados; Botswana; Bermuda; Belgium; Bahamas, The; Belize; Brazil; Brunei; Canada; Sri Lanka; China; Chile; Cayman Islands; Colombia; Costa Rica; Cyprus; Denmark; Dominica; Dominican Republic; Egypt; Ireland; Estonia; El Salvador; Czech Republic; Finland; Fiji; France; Gabon; Ghana; Grenada; Germany; Greece; Guatemala; Hong Kong; Croatia; Hungary; Iceland; India; Israel; Italy; Japan; Jordan; Korea, Republic of; Kuwait; Lebanon; Latvia; Lithuania; Slovakia; Liechtenstein; Lesotho; Luxembourg; Macau; Montserrat; Monaco; Morocco; Mauritius; Malta; Oman; Maldives; Mexico; Malaysia; Vanuatu; Netherlands; Norway; Netherlands Antilles; New Zealand; Paraguay; Peru; Poland; Panama; Portugal; Qatar; Philippines; Saudi Arabia; St. Kitts and Nevis; Seychelles; South Africa; Slovenia; Singapore; Spain; St. Lucia; Sweden; Switzerland; United Arab Emirates; Trinidad and Tobago; Thailand; Tonga; Tunisia; Turkey; Taiwan; United Kingdom; Uruguay; St. Vincent and the Grenadines; Venezuela; British Virgin Islands; Vatican City; Namibia; Western Samoa; Swaziland; Zimbabwe

Principals: 1. Roger I. Gale, CEO 2. Ronald W. Mink, President

Products & Services

Sedia is a leader in the development of novel in-vitro diagnostic assays using alternative fluid specimens (e.g. oral fluid, urine) for disease detection. Sedia is also the leading manufacturer of HIV incidence type assays.

Keywords

  • Manufacture
  • Research
  • Development
  • In-vitro
  • Diagnostic
  • Incidence
  • Tests
  • Assays
  • Rapid
  • Oral
  • Saliva
  • Urine
  • Blood
  • Surveillance
  • Bed
  • Avidity
  • Recency
  • Hiv
  • Dna
  • Sample
  • Collection
  • Ivd

NAICS Code(s)

  • 325413: In-Vitro Diagnostic Substance Manufacturing
  • 325414: Biological Product (except Diagnostic) Manufacturing
  • 541690: Other Scientific and Technical Consulting Services

If you notice any discrepancies in your company profile, or wish to request updates or removals, please contact us to ensure your information is accurate and up-to-date.